Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pramodini MedicareNSE:PRAMODINI -2.01%19 EBIT per Share is ₹2.91 as of Mar. 2026. GuruFocus rates NSE:PRAMODINI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 524 Healthcare Providers & Services companies, Pramodini Medicare ranks better than 78.24% on this metric.
Pramodini Medicare's EBIT per Share for the
three
months ended in Mar. 2026 was ₹2.91.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.91.
During the past 12 months, the average EBIT per Share Growth Rate of Pramodini Medicare was 40.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 36.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Pramodini Medicare's EBIT per Share or its related term are showing as below:
NSE:PRAMODINI'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 36.2 Med: 36.2 Max: 36.2
Current: 36.2
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Pramodini Medicare was 36.20% per year. The lowest was 36.20% per year. And the median was 36.20% per year.
NSE:PRAMODINI's 3-Year EBIT Growth Rate is ranked better than 78.24% of 524
companies
in the Healthcare Providers & Services industry
Industry Median: 11.6
vs NSE:PRAMODINI: 36.20
Pramodini Medicare (NSE:PRAMODINI) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Pramodini Medicare EBIT per Share Related Terms
Pramodini Medicare EBIT per Share Historical Data
* Premium members only.
The historical data trend for Pramodini Medicare's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.91
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare (NSE:PRAMODINI) has a EBIT per Share of ₹2.91 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Pramodini Medicare and its competitors. According to the industry distribution chart, Pramodini Medicare ranks #114 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 21.8%.
Is Pramodini Medicare's EBIT per Share too high?
Pramodini Medicare's current EBIT per Share is ₹2.91. Based on the distribution chart, Pramodini Medicare ranks #114 out of 524 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pramodini Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pramodini Medicare's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pramodini Medicare ranks #114 out of 524 companies for EBIT per Share. This places Pramodini Medicare in the top 22% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 11.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.60, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Pramodini Medicare and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pramodini Medicare's current EBIT per Share is ₹2.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pramodini Medicare stock overvalued right now?
Pramodini Medicare (NSE:PRAMODINI) has a current EBIT per Share of ₹2.91. The current EBIT per Share is ₹2.91. Pramodini Medicare's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Pramodini Medicare (NSE:PRAMODINI), the current EBIT per Share is ₹2.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pramodini Medicare Ltd is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. The company also provide teleradiology services, which functions on a 24*7 basis throughout the year. It provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
19GF Score
Get the complete analysis for NSE:PRAMODINI
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PRAMODINI has been successfully added to your 
